ArticleFrontiers in oncology2023

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma.

Damian T Rieke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.